# GDF6

## Overview
Growth Differentiation Factor 6 (GDF6) is a gene that encodes a protein belonging to the bone morphogenetic protein (BMP) family, which is part of the larger transforming growth factor-beta (TGFβ) superfamily. The protein encoded by GDF6, also known as growth differentiation factor 6, plays a crucial role in various biological processes, including the regulation of vascular stability and the development of skeletal and ocular structures. As a member of the BMP family, GDF6 is involved in signaling pathways that influence cellular differentiation and tissue maintenance, particularly through interactions with type I and type II receptors (Mueller2015Mechanisms). Mutations in the GDF6 gene have been linked to several clinical conditions, such as ocular disorders like Leber congenital amaurosis and skeletal anomalies including Klippel-Feil syndrome, highlighting its significance in human development and disease (AsaiCoakwell2013Contribution; Tassabehji2008Mutations).

## Structure


## Function
Growth Differentiation Factor 6 (GDF6) is a member of the bone morphogenetic protein (BMP) family, which plays a significant role in maintaining vascular stability by modulating vascular endothelial growth factor (VEGF) signaling. In endothelial cells, GDF6 functions to restrain VEGF signaling by reducing the levels of VEGF receptor 2 (VEGFR2), thereby preventing the destabilization of vascular endothelial-cadherin (VECDN), a key component of adherens junctions crucial for vascular integrity (Krispin2018Growth). This regulation helps maintain endothelial barrier function and reduces vascular permeability, which is essential for vascular stability (Krispin2018Growth).

GDF6 is also involved in the development and maintenance of healthy nucleus pulposus (NP) cells in intervertebral discs. It promotes the differentiation of mesenchymal stem cells into NP-like cells and enhances the production of glycosaminoglycans and collagen, which are vital for maintaining NP cell homeostasis (Richardson2018Growth). GDF6 signaling involves both SMAD-dependent and SMAD-independent pathways, such as ERK1/2 and p38 MAPK, which contribute to its role in cellular differentiation and tissue maintenance (Hodgkinson2020Regenerative).

## Clinical Significance
Mutations in the GDF6 gene are associated with a range of ocular and skeletal disorders. In the context of ocular conditions, GDF6 mutations have been linked to early-onset retinal dystrophies, including Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (JRP). These mutations can lead to significant retinal abnormalities, such as altered photoreceptor morphology and increased apoptosis, contributing to severe visual impairment (AsaiCoakwell2013Contribution). GDF6 mutations are also implicated in the microphthalmia, anophthalmia, and coloboma (MAC) spectrum, affecting eye size and development (AsaiCoakwell2009Incomplete; den2010Genetic).

In terms of skeletal disorders, GDF6 mutations are associated with Klippel-Feil syndrome (KFS), characterized by vertebral segmentation defects and congenital fusion of vertebrae. Specific missense mutations, such as p.Ala249Glu and p.Leu289Pro, have been identified in patients with KFS, affecting the prodomain of GDF6 and potentially altering its function (Tassabehji2008Mutations). These mutations can also lead to other skeletal anomalies, including post-axial polydactyly and vertebral fusion (AsaiCoakwell2009Incomplete; den2010Genetic).

The phenotypic variability and incomplete penetrance observed in GDF6-related conditions suggest a complex genetic inheritance pattern, with potential interactions with other genes and environmental factors influencing the clinical outcomes (AsaiCoakwell2009Incomplete).

## Interactions
GDF6, a member of the TGFβ superfamily, interacts with type I and type II receptors, similar to other BMPs and GDFs. It binds to type I receptors BMPRIa (Alk3) and BMPRIb (Alk6) with varying affinities, and the Activin type I receptor (Alk2) is essential for signaling by related ligands like BMP5/6/7 (Mueller2015Mechanisms). The interactions at the ligand–type II receptor interface are characterized by low specificity, dominated by hydrophobic contacts, which allow for promiscuous receptor usage among GDFs, BMPs, and Activins (Mueller2015Mechanisms). 

GDF6, like other GDFs, forms part of a subgroup within the TGFβ superfamily that includes BMPs, which are known for their roles in bone and cartilage development. These proteins can form both homodimers and heterodimers, influencing their biological activity and receptor interactions (Mueller2015Mechanisms). Although specific interactions of GDF6 with other proteins or nucleic acids are not detailed, it shares receptor binding characteristics with other GDFs and BMPs, suggesting similar interaction patterns (Mueller2015Mechanisms). The structural adaptability of these interactions ensures both specificity and promiscuity within the superfamily (Mueller2015Mechanisms).


## References


[1. (Richardson2018Growth) S.M. Richardson, T. Hodgkinson, A. Wei, B. Shen, A. Diwan, and J. Hoyland. Growth differentiation factor 6 promotes a healthy nucleus pulposus cell phenotype through smad and smad-independent signalling pathways. Osteoarthritis and Cartilage, 26:S423, April 2018. URL: http://dx.doi.org/10.1016/j.joca.2018.02.817, doi:10.1016/j.joca.2018.02.817. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.joca.2018.02.817)

[2. (Hodgkinson2020Regenerative) Tom Hodgkinson, Hamish T. J. Gilbert, Tej Pandya, Ashish D. Diwan, Judith A. Hoyland, and Stephen M. Richardson. Regenerative response of degenerate human nucleus pulposus cells to gdf6 stimulation. International Journal of Molecular Sciences, 21(19):7143, September 2020. URL: http://dx.doi.org/10.3390/ijms21197143, doi:10.3390/ijms21197143. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21197143)

[3. (Tassabehji2008Mutations) May Tassabehji, Zhi Ming Fang, Emma N. Hilton, Julie McGaughran, Zhongming Zhao, Charles E. de Bock, Emma Howard, Michael Malass, Dian Donnai, Ashish Diwan, Forbes D.C. Manson, Dédée Murrell, and Raymond A. Clarke. Mutations in gdf6 are associated with vertebral segmentation defects in klippel-feil syndrome. Human Mutation, 29(8):1017–1027, August 2008. URL: http://dx.doi.org/10.1002/humu.20741, doi:10.1002/humu.20741. This article has 152 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20741)

[4. (den2010Genetic) Anneke I den Hollander, Janisha Biyanwila, Peter Kovach, Tanya Bardakjian, Elias I Traboulsi, Nicola K Ragge, Adele Schneider, and Jarema Malicki. Genetic defects of gdf6 in the zebrafish out of sight mutant and in human eye developmental anomalies. BMC Genetics, November 2010. URL: http://dx.doi.org/10.1186/1471-2156-11-102, doi:10.1186/1471-2156-11-102. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2156-11-102)

[5. (Mueller2015Mechanisms) Thomas D. Mueller. Mechanisms of BMP–Receptor Interaction and Activation, pages 1–61. Elsevier, 2015. URL: http://dx.doi.org/10.1016/bs.vh.2015.06.003, doi:10.1016/bs.vh.2015.06.003. This article has 9 citations.](https://doi.org/10.1016/bs.vh.2015.06.003)

[6. (AsaiCoakwell2013Contribution) Mika Asai-Coakwell, Lindsey March, Xiao Hua Dai, Michele DuVal, Irma Lopez, Curtis R. French, Jakub Famulski, Elfride De Baere, Peter J. Francis, Periasamy Sundaresan, Yves Sauvé, Robert K. Koenekoop, Fred B. Berry, W. Ted Allison, Andrew J. Waskiewicz, and Ordan J. Lehmann. Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies. Human Molecular Genetics, 22(7):1432–1442, January 2013. URL: http://dx.doi.org/10.1093/hmg/dds560, doi:10.1093/hmg/dds560. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/dds560)

[7. (AsaiCoakwell2009Incomplete) M. Asai-Coakwell, C. R. French, M. Ye, K. Garcha, K. Bigot, A. G. Perera, K. Staehling-Hampton, S. C. Mema, B. Chanda, A. Mushegian, S. Bamforth, M. R. Doschak, G. Li, M. B. Dobbs, P. F. Giampietro, B. P. Brooks, P. Vijayalakshmi, Y. Sauve, M. Abitbol, P. Sundaresan, V. van Heyningen, O. Pourquie, T. M. Underhill, A. J. Waskiewicz, and O. J. Lehmann. Incomplete penetrance and phenotypic variability characterize gdf6-attributable oculo-skeletal phenotypes. Human Molecular Genetics, 18(6):1110–1121, January 2009. URL: http://dx.doi.org/10.1093/hmg/ddp008, doi:10.1093/hmg/ddp008. This article has 82 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp008)

[8. (Krispin2018Growth) Shlomo Krispin, Amber N. Stratman, Chase H. Melick, Radu V. Stan, Matteo Malinverno, Jamie Gleklen, Daniel Castranova, Elisabetta Dejana, and Brant M. Weinstein. Growth differentiation factor 6 promotes vascular stability by restraining vascular endothelial growth factor signaling. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(2):353–362, February 2018. URL: http://dx.doi.org/10.1161/ATVBAHA.117.309571, doi:10.1161/atvbaha.117.309571. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/ATVBAHA.117.309571)